Cargando…
8th European Conference on Rare Diseases & Orphan Products (ECRD 2016): Edinburgh, UK. 26-28 May 2016
O1 The European Social Preferences Measurement (ESPM) study project: social cost value analysis, budget impact, commercial life cycle revenue management, and the economics of biopharmaceutical Research & Development (R&D) Michael Schlander, Søren Holm, Erik Nord, Jeff Richardson, Silvio Gara...
Ejemplares similares
-
Cost-of-illness studies in heart failure: a systematic review 2004–2016
por: Lesyuk, Wladimir, et al.
Publicado: (2018) -
Cardiac implant registries 2006–2016: a systematic review and summary of global experiences
por: Zhang, Shixuan, et al.
Publicado: (2018) -
Determining Value in Health Technology Assessment: Stay the Course or Tack Away?
por: Caro, J. Jaime, et al.
Publicado: (2018) -
10th European Conference on Rare Diseases & Orphan Products (ECRD 2020)
Publicado: (2020) -
Adrenal Insufficiency in Young Children: a Mixed Methods Study of Parents’ Experiences
por: Simpson, Amy, et al.
Publicado: (2018)